View ValuationTelescope Innovations 将来の成長Future 基準チェック /06現在、 Telescope Innovationsの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Life Sciences 収益成長18.6%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Aug 20Telescope Innovations Corp. Announces Appointment of Dr. E. Neil Lewis to the Board of Directors, Effective August 19, 2026Telescope Innovations Corp. announced the appointment of Dr. Neil Lewis to its Board of Directors (the "Board"), effective August 19, 2026. Dr. Lewis received his PhD in chemistry from the Polytechnic of Wales in the UK and did his postdoctoral fellowship at the National Institutes of Health (NIH) in the USA. He was tenured by the NIH in 1992 holding the position of Senior Biophysical Researcher. He is a Fellow of the Royal Society of Chemistry (FRSC) and a Chartered Chemist (CChem) also conferred by the Royal Society of Chemistry. He is also a Fellow of the Society of Applied Spectroscopy. Dr. Lewis was the founder or co-founder and CEO of three technology companies, including Spectral Dimensions Inc., a company that developed chemical imaging systems for use by the pharmaceutical and other industries. He has authored more than 100 peer reviewed papers and book chapters and is the holder of numerous patents for other novel technologies currently in use by the analytical industry.お知らせ • Jul 16Telescope Innovations Corp. Announces Resignation of Ali Pejman as Board of Directors, Effective 14 July 2026Telescope Innovations Corp. announced that Ali Pejman has resigned from the Company's Board of Directors ("Board"), effective 14 July 2026. Mr. Pejman will remain engaged as a consultant to the Company, pursuant to a consulting agreement to be entered into shortly after Mr. Pejman's resignation. The Board continues to actively search for a qualified candidate to fill the resulting vacancy and will announce the appointment of a successor in due course, in accordance with applicable securities laws and the policies of the Canadian Securities Exchange (the "CSE").お知らせ • Apr 07Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026.お知らせ • Oct 15Telescope Innovations Corp. announced that it has received CAD 6.5 million in fundingOn October 14, 2025, the Telescope Innovations Corp closed the transaction by issuing 5,186,816 common shares of the company at a price CAD 0.25 for the proceeds of CAD 1,296,704 in second and final tranche. A finder’s fee in the amount of CAD 3,500 has been paid by the Company.お知らせ • Jul 04Telescope Innovations Corp. announced that it expects to receive CAD 5 million in fundingTelescope Innovations Corp announced a non-brokered private placement of 20,000,000 shares at issue price CAD 0.25 per share for gross proceeds CAD 5,000,000 on July 3, 2025. The transaction is subject to compliance with applicable regulatory requirementsお知らせ • Feb 24Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025.お知らせ • Feb 05Telescope Innovations Corp. announced that it expects to receive CAD 3 million in fundingTelescope Innovations Corp. announced a non-brokered private placement of 7,500,000 units at a price of CAD 0.40 per unit for the gross proceeds of CAD 3,000,000 on February 4, 2025. Each unit will consist of one common share of the Company and one common share purchase warrant. Each warrant will entitle the holder to purchase an additional common share at a price of CAD 0.75 for a period of thirty-six months. In connection with closing of the Offering, the Company may pay finders’ fees to eligible parties who have assisted in introducing subscribers to the Offering. Completion of the Offering remains subject to regulatory approval.お知らせ • Jan 16Telescope Innovations Corp. Announces the Successful Outcomes of Its Brine-To-Battery ProgramTelescope Innovations Corp. announced the successful outcomes of its Brine-to-Battery Program. Over the past year, Telescope Innovations' proprietary ReCRFTTM recrystallization technology has produced battery-grade (>99% pure) lithium carbonate from a wide variety of North American lithium-containing brines. Direct Lithium Extraction (DLE) eluates were obtained from various producers with lithium brine projects across Canada and the US. Isolating dilute lithium from low-grade brine resources in North America traditionally requires several processing steps and additional reagents, resulting in prohibitive CAPEX and OPEX costs relative to overseas operations. Telescope Innovations' ReCRFTTM collapses the lithium carbonate refining flow sheet, reducing these costs to enable a sustainable, on-shore supply of battery raw materials. ReCRFTTM advantages include: 1. Elimination of polishing steps: Lithium carbonate can be produced directly from DLE concentrates, without traditional feed polishing steps. This reduces reagent, plant equipment, energy, and operating costs. A high tolerance for feed variability: Through the Company's Brine-to-Battery program, ReCRFTTM has demonstrated the production of >99% pure lithium carbonate from eight brine sources, originating from Alberta, Texas, Nevada, and Arkansas, and ranging in original lithium purity from 15% - 93% (Figure 1, bottom). Telescope Innovations has protected ReCRFTTM technology through a patent application under the Patent Cooperation Treaty and additional jurisdictions.お知らせ • Feb 16+ 1 more updateTelescope Innovations Corp. Appoints Henry Dubina as CEOTelescope Innovations Corp. appointed Henry Dubina as Chief Executive Officer. Mr. Dubina brings significant experience to Telescope, having served in General Management positions in the scientific instruments industry for the past 35 years. He served as President and Head of Mettler-Toledo AutoChem for over 20 years, directing the global business from its infancy to global market leadership. Mettler-Toledo Autochem provides technology solutions and services to speed the development of high value, chemical-based processes. AutoChem instruments have been ubiquitously deployed in academia and industry for biopharmaceutical, chemical, and advanced materials applications to boost R&D productivity.お知らせ • Feb 13Telescope Innovations Corp., Annual General Meeting, Apr 18, 2024Telescope Innovations Corp., Annual General Meeting, Apr 18, 2024.お知らせ • Jan 24Telescope Innovations Corp. Files Provisional Patent ApplicationTelescope Innovations Corp. announced it has filed a provisional patent application (63/606,069) on a disruptive new technique to purify lithium carbonate, a critical mineral building block for lithium ion battery production and particularly for low-cost LFP battery chemistries. This is Telescope's second application related to processing battery raw materials, the first of which provides a low-temperature method for generating lithium sulfide. The current provisional application describes a single-step process that produces battery-grade, >99.9% lithium carbonate from crude material of 20-95% purity. This technology can dramatically reduce the requirement for pre-processing of crude lithium brine feeds, which conventionally accounts for up to 80% of refinement costs. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Telescope Innovations は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測OTCPK:TELI.F - アナリストの将来予測と過去の財務データ ( )CAD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数5/31/20267-4-6-6N/A2/28/20267-3-5-5N/A11/30/20256-2-6-5N/A8/31/20255-2-10N/A5/31/20254-201N/A2/28/20254-201N/A11/30/20244-211N/A8/31/20244-100N/A5/31/20244-100N/A2/29/20244-1-1-1N/A11/30/202340-1-1N/A8/31/20233-1-2-2N/A5/31/20233-1-2-1N/A2/28/20232-2-10N/A11/30/20221-5-2-1N/A8/31/20221-6-3-1N/A5/31/2022N/A-6-4-2N/A2/28/2022N/A-8-3-2N/A11/30/2021N/A-5-2-1N/A8/31/2021N/A-4-2-1N/A5/31/2021N/A-300N/A2/28/2021N/A000N/A11/30/2020N/A000N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: TELI.Fの予測収益成長が 貯蓄率 ( 3.7% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: TELI.Fの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: TELI.Fの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: TELI.Fの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: TELI.Fの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: TELI.Fの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/21 07:37終値2026/08/21 00:00収益2026/05/31年間収益2025/08/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Telescope Innovations Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Aug 20Telescope Innovations Corp. Announces Appointment of Dr. E. Neil Lewis to the Board of Directors, Effective August 19, 2026Telescope Innovations Corp. announced the appointment of Dr. Neil Lewis to its Board of Directors (the "Board"), effective August 19, 2026. Dr. Lewis received his PhD in chemistry from the Polytechnic of Wales in the UK and did his postdoctoral fellowship at the National Institutes of Health (NIH) in the USA. He was tenured by the NIH in 1992 holding the position of Senior Biophysical Researcher. He is a Fellow of the Royal Society of Chemistry (FRSC) and a Chartered Chemist (CChem) also conferred by the Royal Society of Chemistry. He is also a Fellow of the Society of Applied Spectroscopy. Dr. Lewis was the founder or co-founder and CEO of three technology companies, including Spectral Dimensions Inc., a company that developed chemical imaging systems for use by the pharmaceutical and other industries. He has authored more than 100 peer reviewed papers and book chapters and is the holder of numerous patents for other novel technologies currently in use by the analytical industry.
お知らせ • Jul 16Telescope Innovations Corp. Announces Resignation of Ali Pejman as Board of Directors, Effective 14 July 2026Telescope Innovations Corp. announced that Ali Pejman has resigned from the Company's Board of Directors ("Board"), effective 14 July 2026. Mr. Pejman will remain engaged as a consultant to the Company, pursuant to a consulting agreement to be entered into shortly after Mr. Pejman's resignation. The Board continues to actively search for a qualified candidate to fill the resulting vacancy and will announce the appointment of a successor in due course, in accordance with applicable securities laws and the policies of the Canadian Securities Exchange (the "CSE").
お知らせ • Apr 07Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026.
お知らせ • Oct 15Telescope Innovations Corp. announced that it has received CAD 6.5 million in fundingOn October 14, 2025, the Telescope Innovations Corp closed the transaction by issuing 5,186,816 common shares of the company at a price CAD 0.25 for the proceeds of CAD 1,296,704 in second and final tranche. A finder’s fee in the amount of CAD 3,500 has been paid by the Company.
お知らせ • Jul 04Telescope Innovations Corp. announced that it expects to receive CAD 5 million in fundingTelescope Innovations Corp announced a non-brokered private placement of 20,000,000 shares at issue price CAD 0.25 per share for gross proceeds CAD 5,000,000 on July 3, 2025. The transaction is subject to compliance with applicable regulatory requirements
お知らせ • Feb 24Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025.
お知らせ • Feb 05Telescope Innovations Corp. announced that it expects to receive CAD 3 million in fundingTelescope Innovations Corp. announced a non-brokered private placement of 7,500,000 units at a price of CAD 0.40 per unit for the gross proceeds of CAD 3,000,000 on February 4, 2025. Each unit will consist of one common share of the Company and one common share purchase warrant. Each warrant will entitle the holder to purchase an additional common share at a price of CAD 0.75 for a period of thirty-six months. In connection with closing of the Offering, the Company may pay finders’ fees to eligible parties who have assisted in introducing subscribers to the Offering. Completion of the Offering remains subject to regulatory approval.
お知らせ • Jan 16Telescope Innovations Corp. Announces the Successful Outcomes of Its Brine-To-Battery ProgramTelescope Innovations Corp. announced the successful outcomes of its Brine-to-Battery Program. Over the past year, Telescope Innovations' proprietary ReCRFTTM recrystallization technology has produced battery-grade (>99% pure) lithium carbonate from a wide variety of North American lithium-containing brines. Direct Lithium Extraction (DLE) eluates were obtained from various producers with lithium brine projects across Canada and the US. Isolating dilute lithium from low-grade brine resources in North America traditionally requires several processing steps and additional reagents, resulting in prohibitive CAPEX and OPEX costs relative to overseas operations. Telescope Innovations' ReCRFTTM collapses the lithium carbonate refining flow sheet, reducing these costs to enable a sustainable, on-shore supply of battery raw materials. ReCRFTTM advantages include: 1. Elimination of polishing steps: Lithium carbonate can be produced directly from DLE concentrates, without traditional feed polishing steps. This reduces reagent, plant equipment, energy, and operating costs. A high tolerance for feed variability: Through the Company's Brine-to-Battery program, ReCRFTTM has demonstrated the production of >99% pure lithium carbonate from eight brine sources, originating from Alberta, Texas, Nevada, and Arkansas, and ranging in original lithium purity from 15% - 93% (Figure 1, bottom). Telescope Innovations has protected ReCRFTTM technology through a patent application under the Patent Cooperation Treaty and additional jurisdictions.
お知らせ • Feb 16+ 1 more updateTelescope Innovations Corp. Appoints Henry Dubina as CEOTelescope Innovations Corp. appointed Henry Dubina as Chief Executive Officer. Mr. Dubina brings significant experience to Telescope, having served in General Management positions in the scientific instruments industry for the past 35 years. He served as President and Head of Mettler-Toledo AutoChem for over 20 years, directing the global business from its infancy to global market leadership. Mettler-Toledo Autochem provides technology solutions and services to speed the development of high value, chemical-based processes. AutoChem instruments have been ubiquitously deployed in academia and industry for biopharmaceutical, chemical, and advanced materials applications to boost R&D productivity.
お知らせ • Feb 13Telescope Innovations Corp., Annual General Meeting, Apr 18, 2024Telescope Innovations Corp., Annual General Meeting, Apr 18, 2024.
お知らせ • Jan 24Telescope Innovations Corp. Files Provisional Patent ApplicationTelescope Innovations Corp. announced it has filed a provisional patent application (63/606,069) on a disruptive new technique to purify lithium carbonate, a critical mineral building block for lithium ion battery production and particularly for low-cost LFP battery chemistries. This is Telescope's second application related to processing battery raw materials, the first of which provides a low-temperature method for generating lithium sulfide. The current provisional application describes a single-step process that produces battery-grade, >99.9% lithium carbonate from crude material of 20-95% purity. This technology can dramatically reduce the requirement for pre-processing of crude lithium brine feeds, which conventionally accounts for up to 80% of refinement costs.